5 resultaten
RELATED APPLICATIONS
This application claims the priority benefit of U.S. Ser. No. 10/777,893, filed Feb. 12, 2004 (now U.S. Pat. No. 7,300,753), and PCT/US04/21670 filed Jul. 7, 2004.
FIELD OF THE INVENTION
The invention relates generally to antibodies and peptide reagents for the detection of
TECHNICAL FIELD
This invention generally relates to drug discovery, medicine and cell biology. In particular, in alternative embodiments, the invention provides pharmaceutical compounds and formulations comprising a family of epoxyketone compounds, which include racemic mixtures or racemates,
BACKGROUND
Field of the Invention
This invention is generally in the field of therapeutic delivery systems including bacteria, and systems and methods for providing chimeric proteins efficiently targeted to cancer cells.
Description of the Prior Art
Citation or identification of any reference
BACKGROUND
Non-Hodgkin lymphoma (NHL) is the 7th most frequent cancer (Siegel et al., 2012). Diffuse large B-cell lymphoma (DLBCL) is the most common subtype of NHL accounting for .about.25% of all lymphoma cases (Swerdlow, 2008). Gene expression profiling allowed subclassification of DLBCL into
INCORPORATION-BY-REFERENCE OF MATERIAL ELECTRONICALLY SUBMITTED
Incorporated by reference in its entirety herein is a computer-readable nucleotide/amino acid sequence listing su currently herewith and identified as follows: One 8,709 Byte SCII (Text) filed named "726179_ST25.TXT," created Feb. 26,